Search Results - Yuki Takamatsu

  • Showing 1 - 14 results of 14
Refine Results
  1. 1
    Ebola virus proteins NP, VP35, and VP24 are essential and sufficient to mediate nucleocapsid transport

    Ebola virus proteins NP, VP35, and VP24 are essential and sufficient to mediate nucleocapsid transport by Yuki Takamatsu, Larissa Kolesnikova, Stephan Becker

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Mechanism of Darunavir (DRV)’s High Genetic Barrier to HIV-1 Resistance: A Key V32I Substitution in Protease Rarely Occurs, but Once It Occurs, It Predisposes HIV-1 To Develop DRV Resistance

    Mechanism of Darunavir (DRV)’s High Genetic Barrier to HIV-1 Resistance: A Key V32I Substitution in Protease Rarely Occurs, but Once It Occurs, It Predisposes HIV-1 To Develop DRV... by Manabu Aoki, Debananda Das, Hironori Hayashi, Hiromi Aoki-Ogata, Yuki Takamatsu, Arun K. Ghosh, Hiroaki Mitsuya

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    The dengue virus conceals double-stranded RNA in the intracellular membrane to escape from an interferon response

    The dengue virus conceals double-stranded RNA in the intracellular membrane to escape from an interferon response by Leo Uchida, Lyre Anni Espada-Murao, Yuki Takamatsu, Kenta Okamoto, Daisuke Hayasaka, Fuxun Yu, Takeshi Nabeshima, Corazon C. Buerano, Kouichi Morita

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Structural basis for Ebola virus nucleocapsid assembly and function regulated by VP24

    Structural basis for Ebola virus nucleocapsid assembly and function regulated by VP24 by Yoko Fujita, Shangfan Hu, Ai Hirabayashi, Yuki Takamatsu, Yen Ni Ng, Kazuya Houri, Yukiko Muramoto, Masahiro Nakano, Yukihiko Sugita, Takeshi Noda

    Published 2025
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Neutralization activity of IgG antibody in COVID‑19‑convalescent plasma against SARS-CoV-2 variants

    Neutralization activity of IgG antibody in COVID‑19‑convalescent plasma against SARS-CoV-2 variants by K. Tsuchiya, Kenji Maeda, Kouki Matsuda, Yuki Takamatsu, Noriko Kinoshita, Satoshi Kutsuna, Tsunefusa Hayashida, Hiroyuki Gatanaga, Norio Ohmagari, Shinichi Oka, Hiroaki Mitsuya

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    SARS-CoV-2-Neutralizing Humoral IgA Response Occurs Earlier but Is Modest and Diminishes Faster than IgG Response

    SARS-CoV-2-Neutralizing Humoral IgA Response Occurs Earlier but Is Modest and Diminishes Faster than IgG Response by Yuki Takamatsu, Kazumi Omata, Yosuke Shimizu, Noriko Kinoshita-Iwamoto, Mari Terada, Tetsuya Suzuki, Shinichiro Morioka, Yukari Uemura, Norio Ohmagari, Kenji Maeda, Hiroaki Mitsuya

    Published 2022
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Restoration of immune surface molecules in Kaposi sarcoma-associated herpes virus infected cells by lenalidomide and pomalidomide

    Restoration of immune surface molecules in Kaposi sarcoma-associated herpes virus infected cells by lenalidomide and pomalidomide by David A. Davis, Suraj Mishra, Holda A. Anagho, Ashley I. Aisabor, Prabha Shrestha, Victoria Wang, Yuki Takamatsu, Kenji Maeda, Hiroaki Mitsuya, Jerome B. Zeldis, Robert Yarchoan

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Neutralization of SARS-CoV-2 with IgG from COVID-19-convalescent plasma

    Neutralization of SARS-CoV-2 with IgG from COVID-19-convalescent plasma by Kenji Maeda, Nobuyo Higashi‐Kuwata, Noriko Kinoshita, Satoshi Kutsuna, K. Tsuchiya, Shin‐ichiro Hattori, Kouki Matsuda, Yuki Takamatsu, Hiroyuki Gatanaga, Shinichi Oka, Haruhito Sugiyama, Norio Ohmagari, Hiroaki Mitsuya

    Published 2021
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    GRL-0920, an Indole Chloropyridinyl Ester, Completely Blocks SARS-CoV-2 Infection

    GRL-0920, an Indole Chloropyridinyl Ester, Completely Blocks SARS-CoV-2 Infection by Shin-ichiro Hattori, Nobuyo Higshi-Kuwata, Jakka Raghavaiah, Debananda Das, Haydar Bulut, David A. Davis, Yuki Takamatsu, Kouki Matsuda, Nobutoki Takamune, Naoki Kishimoto, Tadashi Okamura, Shogo Misumi, Robert Yarchoan, Kenji Maeda, Arun K. Ghosh, Hiroaki Mitsuya

    Published 2020
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    4′‐modified nucleoside analogs: Potent inhibitors active against entecavir‐resistant hepatitis B virus

    4′‐modified nucleoside analogs: Potent inhibitors active against entecavir‐resistant hepatitis B virus by Yuki Takamatsu, Yasuhito Tanaka, Satoru Kohgo, Shuko Murakami, Kamalendra Singh, Debananda Das, David Venzon, Masayuki Amano, Nobuyo Higashi‐Kuwata, Manabu Aoki, Nicole S. Delino, Sanae Hayashi, Satoru Takahashi, Yoshikazu Sukenaga, Kazuhiro Haraguchi, Stefan G. Sarafianos, Kenji Maeda, Hiroaki Mitsuya

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Co-Circulation of Dengue Virus Serotypes 1, 2, and 3 during the 2022 Dengue Outbreak in Nepal: A Cross-Sectional Study

    Co-Circulation of Dengue Virus Serotypes 1, 2, and 3 during the 2022 Dengue Outbreak in Nepal: A Cross-Sectional Study by Sandesh Rimal, Sabin Shrestha, Kishor Pandey, Thanh Vu Nguyen, Parmananda Bhandari, Yogendra Shah, Dhiraj Acharya, Nabaraj Adhikari, Komal Raj Rijal, Prakash Ghimire, Yuki Takamatsu, Basu Dev Pandey, Stefan Fernandez, Kouichi Morita, Mya Myat Ngwe Tun, Shyam Prakash Dumre

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Correlates of neutralizing/SARS-CoV-2-S1-binding antibody response with adverse effects and immune kinetics in BNT162b2-vaccinated individuals

    Correlates of neutralizing/SARS-CoV-2-S1-binding antibody response with adverse effects and immune kinetics in BNT162b2-vaccinated individuals by Kenji Maeda, Masayuki Amano, Yukari Uemura, K. Tsuchiya, Tomoko Matsushima, Kenta Noda, Yosuke Shimizu, Asuka Fujiwara, Yuki Takamatsu, Yasuko Ichikawa, Hidehiro Nishimura, Mari Kinoshita, Shota Matsumoto, Hiroyuki Gatanaga, Kazuhisa Yoshimura, Shinichi Oka, Ayako Mikami, Wataru Sugiura, Toshiyuki Sato, Tomokazu Yoshida, Shinya Shimada, Hiroaki Mitsuya

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    A novel central nervous system-penetrating protease inhibitor overcomes human immunodeficiency virus 1 resistance with unprecedented aM to pM potency

    A novel central nervous system-penetrating protease inhibitor overcomes human immunodeficiency virus 1 resistance with unprecedented aM to pM potency by Manabu Aoki, Hironori Hayashi, Kalapala Venkateswara Rao, Debananda Das, Nobuyo Higashi‐Kuwata, Haydar Bulut, Hiromi Aoki-Ogata, Yuki Takamatsu, Ravikiran S. Yedidi, David A. Davis, Shin-ichiro Hattori, Noriko Nishida, Kazuya Hasegawa, Nobutoki Takamune, Prasanth R. Nyalapatla, Heather L. Osswald, Hirofumi Jono, Hideyuki Saito, Robert Yarchoan, Shogo Misumi, Arun K. Ghosh, Hiroaki Mitsuya

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replication

    A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replication by Shin-ichiro Hattori, Nobuyo Higashi‐Kuwata, Hironori Hayashi, Srinivasa Rao Allu, Jakka Raghavaiah, Haydar Bulut, Debananda Das, Brandon J. Anson, Emma K. Lendy, Yuki Takamatsu, Nobutoki Takamune, Naoki Kishimoto, Kazutaka Murayama, Kazuya Hasegawa, Mi Li, David A. Davis, Eiichi Kodama, Robert Yarchoan, Alexander Wlodawer, Shogo Misumi, Andrew D. Mesecar, Arun K. Ghosh, Hiroaki Mitsuya

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: